Trials / Completed
CompletedNCT05236660
Personalised Assistive Devices Approach for Diabetic Foot Ulcer Prevention
Cost-utility of an Integrated Personalised Assistive Devices Approach to Reduce Foot Ulcer Recurrence in Diabetes (DIASSIST): a Multicentre Randomised Controlled Trial
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 126 (actual)
- Sponsor
- Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Preventing foot ulcers in people with diabetes can reduce costs and increase quality of life. Despite availability of various interventions to prevent foot ulcers, recurrence rates remain high. We hypothesise that a multimodal approach incorporating a variety of orthotic interventions that matches an individual person's need can reduce ulcer recurrence with beneficial cost-effectiveness and cost-utility.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Custom-made shoes: pressure-optimized | Pressure-optimized custom-made shoes: evaluated and optimized using in-shoe pressure analysis, and re-evaluated after 6 months. |
| DEVICE | Custom-made indoor shoes: pressure optimized | Pressure-optimized custom-made indoor shoes: evaluated and optimized using in-shoe pressure analysis, and re-evaluated after 6 months. Specifically designed for indoor use. |
| DEVICE | Foot temperature monitoring | Personalised at-home daily foot temperature monitoring at high-risk regions. |
| BEHAVIORAL | Education | Personalised patient education consisting of quantitative feedback on in-shoe pressures, temperature measurements and footwear use and, in addition, motivational interviewing where indicated and needed to improve device use. |
Timeline
- Start date
- 2022-03-02
- Primary completion
- 2025-10-02
- Completion
- 2025-10-02
- First posted
- 2022-02-11
- Last updated
- 2026-01-06
Locations
5 sites across 1 country: Netherlands
Source: ClinicalTrials.gov record NCT05236660. Inclusion in this directory is not an endorsement.